Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests drug to stop 'Rebound Pain' after shoulder surgery

NCT ID NCT07642674

Recruiting now Symptom relief Sponsor: Eskisehir Osmangazi University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving the anti-inflammatory drug dexketoprofen through a vein can prevent or lessen the severe pain that often occurs when a nerve block wears off after shoulder surgery. About 66 adults having arthroscopic shoulder surgery will be randomly assigned to receive either standard pain treatment or standard treatment plus dexketoprofen. Researchers will track pain scores and the amount of extra pain medicine needed in the first 24 hours after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
dexketoprofen (a nonsteroidal anti-inflammatory drug)
What this could lead to
If it works, this could give doctors a simple way to prevent severe pain after shoulder surgery when the nerve block wears off.
What could go wrong
This is a small, early-stage study (66 people) and the drug may not reduce rebound pain significantly. NSAIDs also carry risks for some patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTERSCALENE BLOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTERSCALENE BLOCK PAIN MANAGEMENT POSTOPERATIVE PAIN REBOUND PAIN

Contacts and locations

Locations

  • Eskisehir Osmangazi Universıty Faculty of Medicine

    RECRUITING

    Eskişehir, Odunpazarı, 26040, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.